Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-20-020453)

Filing Details

Accession Number:: 0001437749-20-020453
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-29 18:28:56
Reporting Period:: 2020-09-29

Accepted Time:: 2020-09-29 18:28:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
832489	Geovax Labs Inc.	GOVX	Pharmaceutical Preparations (2834)	870455038

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1193607	A David Dodd	1900 Lake Park Drive Suite 380 Smyrna GA 30080	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-29	81,870	$5.00	81,870	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Purchase Warrant	Acquisiton	2020-09-29	81,870	$0.00	81,870	$5.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
81,870	2020-09-29	2025-09-29	No	4	P	Direct

Footnotes

These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement.